KDIGO Launches New Implementation Tools for Diabetes Management in CKD |
|
Acknowledging the often lengthy and complex nature of clinical practice guidelines, the KDIGO Diabetes in CKD Visual Guideline and Infographic Set are intended to make key recommendations and practice points more quickly accessible and readily understandable. Topics include comprehensive care, glycemic monitoring and targets, lifestyle and antihyperglycemic interventions, approaches to self-management, and optimal models of care.
The KDIGO Diabetes in CKD Guideline Update is currently underway and is scheduled to publish in 2022. The Diabetes in CKD Visual Guideline and Infographic Set will be updated to include the latest science and recommendations from the Guideline.
|
|
Upcoming Webinars and Events
|
|
Episode 6 of the KDIGO Genetics in CKD Webinar Series
Thursday, February 3 at 11:00 AM (EST)
The KDIGO Genetics in CKD Webinar Series is back with Episode 6: Challenges to Implementing Optimal Genetic Testing for Patients with Kidney Diseases.
Join Dr. Albertien van Eerde (Netherlands) and Dr. Hila Milo Rasouly (United States) as they discuss challenges to implementing optimal genetic testing for patients with kidney diseases and explore examples of local solutions. The webinar will compare and contrast resources and issues in genetic care from a global perspective, and examine the role of nephrologists, clinical geneticists, genetic counselors, and other specialists involved in the care of patients with kidney disease.
|
|
KDIGO at the 2022 World Congress of Nephrology
Saturday, February 26
Are you attending the 2022 International Society of Nephrology (ISN) World Congress of Nephrology (WCN)? Don't miss the KDIGO sessions taking place on Saturday, February 26. Please see additional details below.
KDIGO Glomerular Diseases Guideline: Reflections on a Decade of Progress
Saturday, February 26, 2:30 PM (CET), 9:30 PM (MYT)
Moderated by Dr. Adrien Liew (Singapore), this session will cover key topics from the KDIGO 2021 Glomerular Diseases Guideline and recent advances in the field. Glomerular disease experts and Guideline Work Group members, Dr. Keisha Gibson (United States), Dr. Heather Reich (Canada), and Dr. Jack Wetzels (Netherlands) will each cover a different topic from the KDIGO Glomerular Diseases Guideline.
|
|
A Discussion with KDIGO: Advancing Evidence-Based Care in Diabetes and CKD
Saturday, February 26, 04:00 PM (CET), 11:00 PM (MYT)
This exciting session, supported by the BI and Lilly Alliance, covers a range of critical topics in diabetes care and research. The session, moderated by KDIGO Diabetes Guideline Co-Chair, Dr. Peter Rossing (Denmark), features presentations by diabetes experts and includes a live question-and-answer component. Topics and speakers include:
ADA and KDIGO Consensus Statement on Diabetes Management: A High-Level Summary by Dr. Kathy Tuttle (United States), KDIGO Diabetes in CKD Guideline Work Group Member
The Times They Are a-Changin': Updates from the KDIGO 2022 Diabetes Guideline by Dr. Ian de Boer (United States), KDIGO Diabetes in CKD Guideline Co-Chair
Implementing KDIGO Diabetes Guideline in Practice: Empowering Clinicians and Patients to Improve Outcomes by Dr. Juliana Chan (Hong Kong), KDIGO Diabetes in CKD Guideline Work Group Member
|
|
FSGS: New Guidelines and Emerging Treatments to Reduce Proteinuria to Goals and Slow Decline in Kidney Function
This CME program, produced in collaboration with PlatformQ Health, applies the latest science from KDIGO guidelines on the diagnosis and prognosis of FSGS.
Join Dr. Edgar Lerma (United States), Dr. Sharon Adler (United States), and Dr. Jai Radhakrishnan (United States) as they address the burden of disease on those with FSGS, including the consequences of late diagnoses and the limitations of current therapies.
|
|
KDIGO Novel Anemia Therapies Controversies Conference Recording: HIF Stabilizer Trials in CKD/HD Patients – What Do the Data Really Show?
KDIGO convened a Controversies Conference on Novel Anemia Therapies in December 2021 to determine best practices and areas of uncertainty in the treatment of anemia, address ongoing controversial issues, and identify new topics to be revisited in the KDIGO Anemia Guideline Update.
In this recording from the conference, Dr. Jonathan Barrett (United Kingdom) provides a high-level overview of the clinical trial landscape, the key results from HIF stabilizer trials, and the major unanswered questions from the data, which the Controversies Conference sought to address.
|
|
Download the KDIGO App
The KDIGO App puts KDIGO guidelines, recommendation statements, conference reports, and updates in the palm of your hand. The KDIGO app can be downloaded for free at the Apple Store or Google Play Store.
The KDIGO 2021 Glomerular Diseases Guideline will be the next available in the app. Stay tuned for more updates.
|
|
About KDIGO
KDIGO is a Belgian foundation committed to developing and implementing nephrology guidelines that improve patient outcomes on a global basis. It is an independent, volunteer-led, self-managed charity incorporated in Belgium accountable to the public and the patients it serves.
|
|
|
|
|
|
|
